Repaglinide and related hypoglycemic benzoic acid derivatives.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1998-12-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM9810349PMID 9857091
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.

  1998cited by this paper
• Hypoglycaemic effects of the novel antidiabetic agent repaglinide in rats and dogs

  1997cited by this paper
• PKC-Dependent Stimulation of Exocytosis by Sulfonylureas in Pancreaticβ Cells

  1996cited by this paper
• Conformational analysis of non-sulfonylurea hypoglycemic agents of the meglitinide family.

  1995cited by this paper
• Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets.

  1989cited by this paper
• Acylureidoalkylphenylsulfonylureas with blood glucose lowering efficacy.

  1988cited by this paper
• Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells

  1988cited by this paper
• Stimulation of insulin release by benzoic acid derivatives related to the non-sulphonylurea moiety of glibenclamide: structural requirements and cellular mechanisms.

  1987cited by this paper
• Receptor binding sites of hypoglycemic sulfonylureas and related [(acylamino)alkyl]benzoic acids.

  1984cited by this paper
• Effect of a new hypoglycaemic agent (HB 699) on the in vivo secretion of pancreatic hormones in the dog

  1981cited by this paper
• Blood glucose lowering sulfonamides with asymmetric carbon atoms. 3. Related N-substituted carbamoylbenzoic acids.

  1979cited by this paper
• [Acylaminoalkyl substituted benzoic and phenylalkane acids with hypoglycaemic properties (author's transl)].

  1978cited by this paper
• Blood glucose lowering sulfonamides with asymmetric carbon atoms.

  1974cited by this paper
• Potential local anaesthetics. 3. Basic N-(ring substituted alpha, lpha-dialkylbenzyl)acylamines.

  1970cited by this paper
• [A new highly-active oral antidiabetic].

  1966cited by this paper
• [Not Available].

  1949cited by this paper

• Enantioconvergent Chan-Lam Coupling: Synthesis of Chiral Benzylic Amides via Cu-Catalyzed Deborylative Amidation.

  2025cites this paper
• Integration of Pharmacodynamics, Proteomics, and Metabolomics to Elucidate Effect and Mechanism of Rehmanniae Radix in the Treatment of T2DM

  2025cites this paper
• The Emerging Structural Pharmacology of ATP-Sensitive Potassium Channels

  2022cites this paper
• Metal- and base-free tandem sulfonylation/cyclization of 1,5-dienes with aryldiazonium salts via the insertion of sulfur dioxide

  2022cites this paper
• ABLOS: ATP-binding loop of sulfonylurea receptor

  2022cites this paper
• ABLOS: ATP-binding loop of sulfonylurea receptor

  2022cites this paper
• ABLOS: ATP-binding loop of sulfonylurea receptor

  2022cites this paper
• ABLOS: ATP-binding loop of sulfonylurea receptor

  2022cites this paper
• ABLOS: ATP-binding loop of sulfonylurea receptor

  2022cites this paper
• The interplay of intra- and intermolecular errors in modeling conformational polymorphs.

  2022cites this paper
• Solubility Enhancement of Antidiabetic Drugs Using a Co‐Crystallization Approach

  2021cites this paper
• Substrate-dependent regiodivergent three-component condensation of 1H-pyrrole-2,3-diones, malononitrile and 4-hydroxyquinolin-2(1H)-ones

  2021cites this paper
• Iridium-catalyzed C-H methylation and d 3-methylation of benzoic acids with application to late-stage functionalizations.

  2021cites this paper
• Therapeutically relevant natural products as AMPK activators in the treatment of diabetes

  2020cites this paper
• Potentiometric CheqSol and Standardized Shake-Flask Solubility Methods are Complimentary Tools in Physicochemical Profiling.

  2020cites this paper
• LC-MS/MS Characterization of Forced Degradation Products of Repaglinide Quality by Design Approach for Stability-Indicating LC Method Development and Validation for Degradation Products

  2020cites this paper
• Nucleophilic Imines and Electrophilic o-Quinone Methides, a Three-Component Assembly of Assorted 3,4-Dihydro-2H-1,3-benzoxazines.

  2019cites this paper
• The first insight into the supramolecular structures of popular drug repaglinide: Focus on intermolecular interactions in antidiabetic agents

  2019cites this paper
• Novel urate transporter 1 (URAT1) inhibitors: a review of recent patent literature (2016–2019)

  2019cites this paper
• Preparation, Characterization and Crystal Structures of a Key Intermediate, and a Significant Impurity, in the Synthesis of Repaglinide

  2019cites this paper
• Synthesis of new arylsulfonylspiroimidazolidine-2',4'-diones and study of their effect on stimulation of insulin release from MIN6 cell line, inhibition of human aldose reductase, sorbitol accumulations in various tissues and oxidative stress.

  2019cites this paper
• Structural insights into the inhibitory mechanism of insulin secretagogues on the pancreatic ATP-sensitive potassium channel.

  2019cites this paper
• Boron-Catalyzed N-Alkylation of Arylamines and Arylamides with Benzylic Alcohols.

  2019cites this paper
• Main-Group-Catalyzed Reductive Alkylation of Multiply Substituted Amines with Aldehydes Using H2.

  2018cites this paper
• Antidiabetic Drugs (A10)

  2018cites this paper
• Identification, isolation, and synthesis of seven novel impurities of anti-diabetic drug Repaglinide.

  2018cites this paper
• Conformational flexibility and packing plausibility of repaglinide polymorphs

  2018cites this paper
• PHARMACEUTICAL DOSAGE FORMS WITH RAPIDACTIVE PRINCIPLE RELEASE

  2017cites this paper
• Conformation of repaglinide: A solvent dependent structure

  2017cites this paper
• A New Route for the Synthesis of the Repaglinide Key Intermediate 3-Ethoxy-4-Ethoxycarbonylphenylacetic Acid

  2016cites this paper
• Use of Catalysis for API Manufacturing

  2016cites this paper
• Hyperglycemic and Hypoglycemic Drugs

  2016cites this paper
• Synthesis of Repaglinide Congeners

  2015cites this paper
• Synthesis, characterization, hypoglycemic and aldose reductase inhibition activity of arylsulfonylspiro[fluorene-9,5'-imidazolidine]-2',4'-diones.

  2015cites this paper
• Structurally Distinct Ligands Rescue Biogenesis Defects of the KATP Channel Complex via a Converging Mechanism*

  2015cites this paper
• Evidence for a KATP Channel in Rough Endoplasmic Reticulum (rerKATP Channel) of Rat Hepatocytes

  2015cites this paper
• Antidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism.

  2015cites this paper
• ADDITION OF SITAGLIPTIN TO REPAGLINIDE IMPROVES PANCREATIC ISLET PROLIFERATION AND INSULIN PRODUCTION IN EXPERIMENTALLY-INDUCED TYPE 2 DIABETES IN RATS

  2014cites this paper
• Reversal Diastereoselectivity Between the Organomagnesium and Organolithium Reagents on Chiral N-Tert-Butylsulfinylaldimines for the Preparation of Chiral Amines

  2014cites this paper
• STABLE COLLOIDAL CHITOSAN/ALGINATE NANOCOMPLEXES: FABRICATION, FORMULATION OPTIMIZATION AND REPAGLINIDE LOADING

  2014cites this paper
• Two polymorphs of 2-ethyl-3-hydroxy-6-methylpyridinium hydrogen N-acetyl-L-glutamate from powder diffraction data.

  2013influential citation
• N-tert-butyl-N'-[5-cyano-2-(4-methylphenoxy)phenylsulfonyl]urea, a new TXA₂ receptor antagonist.

  2013cites this paper
• POLAROGRAPHIC BEHAVIOR AND QUANTIFICATION OF THE ANTI-DIABETIC DRUG REPAGLINIDE IN PURE FORM AND PHARMACEUTICAL FORMULATIONS

  2013cites this paper
• Discovering New Medicines Targeting Helicases: Challenges and Recent Progress

  2013cites this paper
• Synthesis of novel β-amino ketones containing a p -aminobenzoic acid moiety and evaluation of their antidiabetic activities

  2013cites this paper
• Synthesis of novel β-amino ketones containing a p-aminobenzoic acid moiety and evaluation of their antidiabetic activities

  2013cites this paper
• Preparation and refining method of repaglinide

  2012cites this paper
• Alternative efficient tritium labeling of repaglinide

  2012cites this paper
• Method for preparing high-purity repaglinide

  2012cites this paper
• Validated stability-indicating RP-HPLC UV method for simultaneous determination of metformin and repaglinide

  2012cites this paper
• Funktionalisierung von C‐H‐Bindungen: neue Synthesemethoden für Naturstoffe und Pharmazeutika

  2012cites this paper
• The Role of Sulphonylureas in the Management of Type 2 Diabetes Mellitus

  2012cites this paper
• C-H bond functionalization: emerging synthetic tools for natural products and pharmaceuticals.

  2012cites this paper
• Gliquidone

  2011cites this paper
• Small molecule inhibitors of the human papillomavirus E1-E2 interaction.

  2011influential citation
• Palladium-catalyzed intermolecular directed C-H amidation of aromatic ketones.

  2011cites this paper
• Hydrophobicity--shake flasks, protein folding and drug discovery.

  2010cites this paper
• Conformational polymorphism in sulfonylurea drugs: electronic structure analysis.

  2010cites this paper
• Diabetes Drugs: Present and Emerging

  2010cites this paper
• In vitro characterization and invivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles.

  2010cites this paper
• Repaglinide versus Metformin in controlling post-prandial hyperglycemia in type II diabetics .

  2009cites this paper
• Design, synthesis, and evaluation of indolinones as triple angiokinase inhibitors and the discovery of a highly specific 6-methoxycarbonyl-substituted indolinone (BIBF 1120).

  2009cites this paper
• Preparation of 5‐nitro‐2‐amino[b]thiophenes and 1‐(2‐amino‐5‐nitrophenyl)ethanones via microwave irradiation

  2009cites this paper
• Association of KCNJ11 and ABCC8 genetic polymorphisms with response to repaglinide in Chinese diabetic patients

  2008cites this paper
• Verfahren zur Erzeugung von weitgehend optisch reinem Repaglinid und seinen Vorläufern

  2008cites this paper
• Asymmetric addition of phenylzinc reagents to C-alkynyl nitrones. Enantiomeric enhancement by a product-like additive

  2008cites this paper
• Nine-membered Rings

  2008cites this paper
• Novel β-lactam condensed 3-thiaquinolines: an efficient synthesis and structural characterization

  2008cites this paper
• Synthesis and biological activity of imidazopyridine anticoccidial agents: Part II.

  2007cites this paper
• Applications of menthol in synthetic chemistry.

  2007cites this paper
• Rapidly dissolving repaglinide powders produced by the ultra-rapid freezing process

  2007cites this paper
• Defining a binding pocket for sulfonylureas in ATP‐sensitive potassium channels

  2007cites this paper
• Monitoring ibuprofen release from multiparticulates: In situ fiber-optic technique versus the HPLC method: A technical note

  2007cites this paper
• Synthesis and evaluation of a classical 2,4-diamino-5-substituted-furo[2,3-d]pyrimidine and a 2-amino-4-oxo-6-substituted-pyrrolo[2,3-d]pyrimidine as antifolates.

  2006cites this paper
• Sulfonylureas Correct Trafficking Defects of Disease-causing ATP-sensitive Potassium Channels by Binding to the Channel Complex*

  2006cites this paper
• Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.

  2006cites this paper
• Repaglinide synthesis process

  2006cites this paper
• Selectivity of repaglinide and glibenclamide for the pancreatic over the cardiovascular KATP channels

  2006cites this paper
• Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes.

  2006cites this paper
• Insulin secretagogues, sulfonylurea receptors and K(ATP) channels.

  2005cites this paper
• Repaglinide has more beneficial effect on cardiovascular risk factors than glimepiride: data from meal-test study.

  2005cites this paper
• Synthesis of ortho‐Methoxyphenylsulfonylsemicarbazides

  2004cites this paper
• Toward linking structure with function in ATP-sensitive K+ channels.

  2004cites this paper
• Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)-4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repaglinide): a potential beta-cell imaging agent.

  2004cites this paper
• Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).

  2004cites this paper
• Investigation of structure-activity relationships in a series of glibenclamide analogues.

  2004cites this paper
• Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic β-cell mass with positron emission tomography (PET)

  2004cites this paper
• Design, synthesis and biological evaluation of 10-CF3CO-DDACTHF analogues and derivatives as inhibitors of GAR Tfase and the de novo purine biosynthetic pathway.

  2003cites this paper
• The mechanisms underlying the unique pharmacodynamics of nateglinide

  2003cites this paper
• Formes cristalline et amorphe de (s)-repaglinide et procedes de preparation

  2003cites this paper
• Synthesis and hypoglycemic evaluation of substituted pyrazole-4-carboxylic acids.

  2002cites this paper
• The pathophysiologic basis of efficacy and clinical experience with the new oral antidiabetic agents.

  2002cites this paper
• Differential interactions of nateglinide and repaglinide on the human beta-cell sulphonylurea receptor 1.

  2002cites this paper
• N-ureidoalkyl-piperidines utiles comme modulateurs de l'activite du recepteur de chimiokine

  2001cites this paper
• Rapid acting insulinotropic agents: restoration of early insulin secretion as a physiologic approach to improve glucose control.

  2001cites this paper
• Effect of repaglinide on cloned beta cell, cardiac and smooth muscle types of ATP-sensitive potassium channels

  2001cites this paper
• Hydrophobicity: is LogP(o/w) more than the sum of its parts?

  2000cites this paper
• DERIVES DE 3-AMINOPIPERIDINE UTILISES COMME ANTAGONISTES DE L'INTEGRINE αvβ3

  2000cites this paper
• The tolbutamide site of SUR1 and a mechanism for its functional coupling to KATP channel closure

  1999cites this paper
• Improving management of type 2 diabetes mellitus: 4. Meglitinides.

  1999cites this paper